← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Op-T-Mune, Inc.
Aurora, CO
$4,449,166
Total funding
6
Grants
Funding over time
peak $1.6M · FY2012–20$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,449,166 · 6
By mechanism
R42$3,340,969 · 2
R41$808,197 · 3
R43$300,000 · 1
Investigators at Op-T-Mune, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Developing a Small Peptide to Control Autoimmune Inflammation In Type 1 Diabetes$1,000,000
R42 · FY2019 · AI
Developing a Small Peptide to Control Autoimmune Inflammation In Type 1 Diabetes$764,501
R42 · FY2020 · AI
Development of a Clinical Screening Platform for Type 1 Diabetes$594,177
R42 · FY2019 · DK
Development of a Clinical Screening Platform for Type 1 Diabetes$561,109
R42 · FY2018 · DK
Development of a Clinical Screening Platform for Type 1 Diabetes$421,182
R42 · FY2017 · DK
Screening for Type 1 Diabetes: A blood test based on the CD40 biomarker$300,000
R43 · FY2012 · HD
Screening for the autoimmune component of multiple sclerosis$299,002
R41 · FY2017 · AI
Developing a small peptide to control autoimmune inflammation in type 1 diabetes$297,387
R41 · FY2017 · AI
Developing a new treatment for MS: Controlling CD40 in EAE$211,808
R41 · FY2014 · AI